Implementierungsleitfaden Therapieziele Onkologie
1.0.0-ballot - Ballot Germany

Implementierungsleitfaden Therapieziele Onkologie - Local Development build (v1.0.0-ballot) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

: Geplante Systemtherapie – Pembrolizumab + Chemotherapie (KEYNOTE-522, Beispiel)

Raw xml | Download


<MedicationRequest xmlns="http://hl7.org/fhir">
  <id value="MedicationRequestPembroChemoNeoadjuvantMamma"/>
  <meta>
    <profile
             value="https://bih-cei.de/fhir/therapieziele-onkologie/StructureDefinition/onko-tumorboard-medication-request"/>
  </meta>
  <language value="de"/>
  <text>
    <status value="extensions"/>
    <div xml:lang="de" lang="de"><hr/><p><b>German</b></p><hr/><p class="res-header-id"><b>Generated Narrative: MedicationRequest MedicationRequestPembroChemoNeoadjuvantMamma</b></p><a name="MedicationRequestPembroChemoNeoadjuvantMamma"> </a><a name="hcMedicationRequestPembroChemoNeoadjuvantMamma"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-onko-tumorboard-medication-request.html">Tumorboard MedicationRequest</a></p></div><p><b>EnLiST-Änderungstyp (Extension)</b>: <span title="Codes:{https://bih-cei.de/fhir/therapieziele-onkologie/CodeSystem/enlist-change-type new}">New LoT</span></p><p><b>status</b>: Completed</p><p><b>intent</b>: Plan</p><p><b>category</b>: <span title="Codes:{http://loinc.org 85232-7}">Tumor board Consult note</span></p><p><b>medication</b>: <span title="Codes:">Pembrolizumab + Carboplatin/Paclitaxel, gefolgt von Pembrolizumab + Epirubicin/Cyclophosphamid (KEYNOTE-522)</span></p><p><b>subject</b>: <a href="Patient-PatientinMamma.html">Sabine Baumann  Female, DoB: 1977-06-24</a></p></div>
  </text>
  <extension
             url="https://bih-cei.de/fhir/therapieziele-onkologie/StructureDefinition/enlist-change">
    <valueCodeableConcept>
      <coding>
        <system
                value="https://bih-cei.de/fhir/therapieziele-onkologie/CodeSystem/enlist-change-type"/>
        <code value="new"/>
        <display value="New LoT"/>
      </coding>
    </valueCodeableConcept>
  </extension>
  <status value="completed"/>
  <intent value="plan"/>
  <category>
    <coding>
      <system value="http://loinc.org"/>
      <code value="85232-7"/>
      <display value="Tumor board Consult note"/>
    </coding>
  </category>
  <medicationCodeableConcept>
    <text
          value="Pembrolizumab + Carboplatin/Paclitaxel, gefolgt von Pembrolizumab + Epirubicin/Cyclophosphamid (KEYNOTE-522)"/>
  </medicationCodeableConcept>
  <subject>🔗 
    <reference value="Patient/PatientinMamma"/>
  </subject>
</MedicationRequest>